"Phil Holberton's experience, wisdom and judgment have contributed substantively to me and to Genome Therapeutics' performance. The discipline he brought to the project management of GTC has been superb... He is a real professional and a pleasure to work with."

Robert A. Hennessey
Chairman & Former CEO
Genome Therapeutics Corporation

"Phil provided timely...support, guidance and, if requested, tactical execution for financial and critical path issues for our new company...he was of great value in discussing broad, strategic [issues] and day-to-day issues."

John M. Carnuccio
President and CEO
BioSphere Medical, Inc.

"Phil Holberton joined Barbour Stockwell's Board of Directors at the board's inception...He has proved to be a valuable resource. As a growing company, we have particularly appreciated his advice in strategizing as well as in the operational issues involved in managing projects and financing."

Kenneth Maillar
President and CEO
Barbour Stockwell Incorporated

"[Phil's] message regarding the distinctions between 'leadership' and 'management' was very much to the point at this stage of our company's growth. As we move upward to the next level with Segue, we must be ever more aware that only leadership of a very high quality can lead us where we need to go."

Steve Butler
CEO, Segue

"Phil was instrumental in bringing me on board as President and COO of Genome Therapeutics and has been a much valued colleague whose counsel I trust and in whom I have come to have considerable reliance for input and advice on strategic direction and tactics."

Dr. Richard D. Gill
President and COO
Genome Therapeutics Corporation